Brand Name | Status | Last Update |
---|---|---|
xyntha | Biologic Licensing Application | 2011-01-13 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemophilia a | D006467 | EFO_0007267 | D66 | 46 | 38 | 113 | 52 | 118 | 343 |
Hemophilia b | D002836 | — | D67 | 2 | 2 | 12 | 2 | 11 | 28 |
Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | 4 | 1 | 10 | 2 | 10 | 26 |
Von willebrand diseases | D014842 | EFO_0003910 | D68.0 | 1 | 2 | 14 | 3 | 2 | 21 |
Hemostatic disorders | D020141 | — | — | 4 | 2 | 7 | 3 | 6 | 21 |
Hemorrhage | D006470 | MP_0001914 | R58 | — | — | 4 | 3 | 5 | 12 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | 1 | 1 | 2 | 2 | 4 | 9 |
Inherited blood coagulation disorders | D025861 | — | — | — | — | 1 | 1 | 3 | 5 |
Recurrence | D012008 | — | — | — | — | — | 1 | 2 | 3 |
Joint diseases | D007592 | — | M12.9 | — | — | — | 1 | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Coagulation protein disorders | D020147 | — | — | — | — | 2 | — | 3 | 5 |
Hemorrhagic disorders | D006474 | — | D69.9 | — | — | 2 | — | 2 | 4 |
Type 3 von willebrand disease | D056729 | Orphanet_166096 | D68.03 | 1 | — | 1 | — | 2 | 4 |
Inborn genetic diseases | D030342 | EFO_0000508 | — | — | — | 1 | — | 2 | 3 |
X-linked genetic diseases | D040181 | — | — | — | — | 1 | — | 1 | 2 |
Bone diseases | D001847 | — | M89.9 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | 1 | — | — | — | 5 |
Genetic therapy | D015316 | — | — | 1 | 1 | — | — | 1 | 2 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | — | — | 1 |
Raynaud disease | D011928 | EFO_1001145 | I73.0 | — | 1 | — | — | — | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | 1 | — | — | — | 1 |
Glioblastoma | D005909 | EFO_0000515 | — | — | 1 | — | — | — | 1 |
Hemostasis | D006487 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | — | — | — | — | 1 |
Menorrhagia | D008595 | EFO_0003945 | N92.0 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | — | — | 3 | 3 |
Sclerosis | D012598 | — | — | — | — | — | — | 3 | 3 |
Motor activity | D009043 | EFO_0003940 | — | — | — | — | — | 2 | 2 |
Thrombosis | D013927 | — | — | — | — | — | — | 2 | 2 |
Infertility | D007246 | EFO_0000545 | — | — | — | — | — | 2 | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
Seroma | D049291 | — | — | — | — | — | — | 1 | 1 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | — | — | — | 1 | 1 |
Replacement arthroplasty | D019643 | — | — | — | — | — | — | 1 | 1 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | — | — | — | 1 | 1 |
Drug common name | Moroctocog alfa |
INN | moroctocog alfa |
Description | Moroctocog alfa (trade name ReFacto in the EU) is a recombinant antihemophilic factor genetically engineered from Chinese hamster ovary (CHO) cell line. Chemically it is a glycoprotein. It is manufactured by Genetics Institute, Inc. and used to control and prevent hemorrhagic bleeding and prophylaxis associated with surgery or to reduce the number of spontaneous bleeding episodes in patients with hemophilia A. It is partially a recombinant coagulation factor VIII since it has an amino acid sequence which compares to the 90 + 80 kDa form of factor VIII (BDDrFVIII). It also has posttranslational modifications which are similar to those of the plasma-derived molecule. It can not prevent hemorrhagic bleeding associated with von Willebrand's disease since it is not a von Willebrand factor.
|
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109137 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB13999 |
UNII ID | 113E3Z3CJJ (ChemIDplus, GSRS) |